Nikko Asset Management Americas’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-351,213
Closed -$172K 199
2023
Q2
$172K Hold
351,213
﹤0.01% 197
2023
Q1
$390K Sell
351,213
-21,152
-6% -$38.7K ﹤0.01% 196
2022
Q4
$998K Sell
372,365
-16,427
-4% -$43.3K 0.01% 184
2022
Q3
$1.09M Sell
388,792
-7,602
-2% -$32.3K 0.01% 180
2022
Q2
$1.81M Sell
396,394
-16,809
-4% -$88.1K 0.02% 164
2022
Q1
$2.98M Sell
413,203
-32,749
-7% -$271K 0.02% 149
2021
Q4
$7.8M Buy
445,952
+117,900
+36% +$2.54M 0.04% 122
2021
Q3
$6.33M Buy
328,052
+193,707
+144% +$7.37M 0.03% 131
2021
Q2
$5.88M Buy
134,345
+57,280
+74% +$2.66M 0.02% 140
2021
Q1
$3.87M Buy
77,065
+8,423
+12% +$574K 0.02% 163
2020
Q4
$6.14M Buy
+68,642
New +$5.77M 0.03% 144

Other funds holding CELL

Nikko Asset Management Americas's CELL Position: Q3 2023 in Review

Nikko Asset Management Americas sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 351,213 shares — an estimated $172K sold.

Nikko Asset Management Americas first reported a position in CELL in Q4 2020 and held it in 11 quarters. The position peaked at $7.8M in Q4 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Nikko Asset Management Americas reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nikko Asset Management Americas sold 351,213 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $172K.
  • Nikko Asset Management Americas first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Nikko Asset Management Americas's PhenomeX Inc. Common Stock position peaked at $7.8M in Q4 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Nikko Asset Management Americas's 13F filing for Q3 2023, filed 9 Nov 2023.